SEC Form 4 research

NOVEN PHARMACEUTICALS INC insider transactions

Inspect NOVEN PHARMACEUTICALS INC's public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-07T00:29:11.873Z

Issuer CIK
0000815838
Reporting owners
28
Officers and directors
11

Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

No records are available for this view.

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

DENKHAUS DONALD A000127843913
GRANADILLO PEDRO P000121754449
Brandt Peter C.000143409940
ABRAO EDUARDO G00012598628
BARRETT DIANE000122409219
EISENBERG JEFFREY F000122409627
JONES W NEIL00012240979
MANTELLE JUAN A00012240985
PRICE MICHAEL DENNIS000124731315
SATOW PHILLIP M000122433812
STRAUSS ROBERT C00012241004
Yetter Wayne P.00012151203

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.